Kbc Group Nv Zynerba Pharmaceuticals, Inc. Transaction History

Kbc Group Nv

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$5.59 - $10.45 $3,633 - $6,792	-650 Closed	0 $0
Q2 2018 Dec 03, 2019	BUY	$7.98 - $12.39 $5,187 - $8,053	650 New	650 $6,000
Q2 2018 Aug 03, 2018	SELL	$7.98 - $12.39 $5,187 - $8,053	-650 Closed	0 $0
Q1 2018 Dec 03, 2019	BUY	$8.49 - $13.46 $5,518 - $8,749	650 New	650 $6,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.